| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030632 |
| Receipt No. | R000034977 |
| Scientific Title | Diagnostic accuracy of fecal Helicobacter pylori antigen rapid detection reagent and gene detection reagent |
| Date of disclosure of the study information | 2017/12/29 |
| Last modified on | 2020/01/04 (Ver. 6) |
| Basic information | ||
| Public title | Diagnostic accuracy of fecal Helicobacter pylori antigen rapid detection reagent and gene detection reagent | |
| Acronym | Diagnostic accuracy of fecal Helicobacter pylori antigen rapid detection reagent and gene detection reagent | |
| Scientific Title | Diagnostic accuracy of fecal Helicobacter pylori antigen rapid detection reagent and gene detection reagent | |
| Scientific Title:Acronym | Diagnostic accuracy of fecal Helicobacter pylori antigen rapid detection reagent and gene detection reagent | |
| Region |
|
|
| Condition | |||
| Condition | Helicobacter pylori | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | YES | ||
| Objectives | |
| Narrative objectives1 | Our test reagent is evaluated for correlation with fecal H. pylori antigen test kit (Wakamoto Pharmaceutical Co., Ltd.) and real time PCR method. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1, Our fecal H. pylori antigen detection reagent is evaluated for correlation with fecal H. pylori antigen test kit (Wakamoto Pharmaceutical Co., Ltd.)
2, Our fecal H. pylori antigen test kit is evaluated for correlation with real time PCR method. 3, Our fecal H. pylori gene detection reagentis evaluated for correlation with fecal H. pylori antigen test kit (Wakamoto Pharmaceutical Co., Ltd.) 4,Our fecal H. pylori gene detection reagentis evaluated for correlation with real time PCR method. 5,Our fecal H. pylori gene detection reagentis evaluated for correlation with PCR Direct Sequence Method. |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | In Saga Prefecture's commissioned project "Stomach Cancer Prevention Project for the Future", student who receive H. pylori antigen test in feces is eligible. | |||
| Key exclusion criteria | 1, Person who do not obtain consent from principal or substitute (guardian).
2,Person who has judged that the research director has a problem in participation. 3,Person who have already taken H. pylori eradication treatment. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Saga University Faculty of Medicine | ||||||
| Division name | Pediatrics | ||||||
| Zip code | 849-8501 | ||||||
| Address | 5-1-1 Nabeshima, Saga-City, 849-8501 Japan | ||||||
| TEL | 0952-34-2314 | ||||||
| kakiucht@cc.saga-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Saga University Hospital | ||||||
| Division name | Clinical Research Center | ||||||
| Zip code | 849-8501 | ||||||
| Address | 5-1-1 Nabeshima, Saga-City, 849-8501 Japan | ||||||
| TEL | 0952-34-3400 | ||||||
| Homepage URL | |||||||
| kenkyu-shinsei@ml.cc.saga-u.ac.jp | |||||||
| Sponsor | |
| Institute | Saga University Faculty of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MIZUHO MEDY Co Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | CLINICAL RESEARCH CENTER, SAGA UNIVERSITY HOSPITAL |
| Address | 5-1-1 Nabeshima, saga-City, 849-8501 Japan |
| Tel | 0952-34-3400 |
| kenkyu-shinsei@ml.cc.saga-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.hospital.med.saga-u.ac.jp/chiken/data/rinsyou_gijigaiyou/H29.04rinsyou_gijigaiyou.pdf |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | https://www.hospital.med.saga-u.ac.jp/chiken/data/rinsyou_gijigaiyou/H29.04rinsyou_gijigaiyou.pdf | ||||||
| Number of participants that the trial has enrolled | |||||||
| Results | Of the 57 middle school students with H. pylori, the Nested PCR-QP test results of 53 (90.3%) could be analyzed; 28 students were found to have CAM resistance mutations. The results indicating genetic mutation in 28 and no mutation in 23 students were consistent with those of PCR-direct sequencing. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | The subjects were middle school students in Saga Prefecture who underwent H. pylori testing between August and December 2017 under our program to eliminate gastric cancer. Consent to participate in the study was obtained from 71 middle school students. |
||||||
| Participant flow | Of the 57 middle school students with H. pylori, the Nested PCR-QP test results of 53 (90.3%) could be analyzed; 28 students were found to have CAM resistance mutations. The results indicating genetic mutation in 28 and no mutation in 23 students were consistent with those of PCR-direct sequencing. |
||||||
| Adverse events | None |
||||||
| Outcome measures | Nested PCR-QP detection sensitivity and correlation with eradication therapy |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | We confirmed its clinical usefulness by conducting performance evaluation using clinical specimens for newly developed "H. pylori antigen rapid detection reagent in faeces" and "H. pylori gene detection reagent in feces" . |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034977 |